Skip to main content
. 2014 Sep 5;171(21):4820–4830. doi: 10.1111/bph.12590

Table 2.

Effects of HNHA on body and organ weight changes in BDL rats

Groups Body weight (g) Organ weight
Liver (g) Spleen (g) Liver/body (%) Spleen/body (%)
SHAM Veh 346 ± 7.9 14.00 ± 0.29 1.07 ± 0.07 3.86 ± 0.11 0.30 ± 0.05
Meloxicam 368 ± 9.0 14.35 ± 0.33 1.12 ± 0.05 3.89 ± 0.10 0.30 ± 0.02
SAHA 360 ± 4.2 13.56 ± 0.19 1.08 ± 0.02 3.76 ± 0.05 0.29 ± 0.03
HNHA 353 ± 5.9 13.65 ± 0.17 1.03 ± 0.09 3.86 ± 0.07 0.29 ± 0.05
BDL Veh 298 ± 4.7 21.13 ± 1.02 2.09 ± 0.12 7.08 ± 0.95 0.70 ± 0.11
Meloxicam 308 ± 5.5*;##; 18.00 ± 0.97*;##; 1.80 ± 0.55*;##; 5.84 ± 0.45*;##; 0.58 ± 0.05*;#;
SAHA 311 ± 6.4*;#; 15.74 ± 0.51**;#; 1.52 ± 0.43**;#; 5.06 ± 0.41**;#; 0.49 ± 0.52**;#;
HNHA 324 ± 5.1**; 14.05 ± 2.06***; 1.32 ± 0.55***; 4.33 ± 0.54**; 0.40 ± 0.05**;

Meloxicam was injected i.m. at a daily dose of 1.6 mg, and SAHA and HNHA were injected i.p. in rats at a dose of 30 mg·kg−1 once every 3 days for 3 weeks. Data shown are means ± SEM.

*

P < 0.05,

**

P < 0.01,

***

P < 0.005 versus BDL;

#

P < 0.05,

##

P < 0.01 versus BDL + HNHA.